Althof N, Harkins S, Kemball CC, Flynn CT, Alirezaei M, Whitton JL (2014) In vivo ablation of type I interferon receptor from cardiomyocytes delays coxsackieviral clearance and accelerates myocardial disease. J Virol 88:5087–5099
Article PubMed PubMed Central Google Scholar
Barral PM, Sarkar D, Fisher PB, Racaniello VR (2009) RIG-I is cleaved during picornavirus infection. Virology 391:171–176
Article CAS PubMed Google Scholar
Bass-Zubek AE, Godsel LM, Delmar M, Green KJ (2009) Plakophilins: multifunctional scaffolds for adhesion and signaling. Curr Opin Cell Biol 21:708–716
Article CAS PubMed PubMed Central Google Scholar
Bouin A, Gretteau PA, Wehbe M, Renois F, N’Guyen Y, Leveque N, Vu MN, Tracy S, Chapman NM, Bruneval P, Fornes P, Semler BL, Andreoletti L (2019) Enterovirus persistence in cardiac cells of patients with idiopathic dilated cardiomyopathy is linked to 5’ terminal genomic RNA-deleted viral populations with viral-encoded proteinase activities. Circulation 139:2326–2338
Article CAS PubMed PubMed Central Google Scholar
Chen Y, Pat B, Zheng J, Cain L, Powell P, Shi K, Sabri A, Husain A, Dell’italia LJ (2010) Tumor necrosis factor-alpha produced in cardiomyocytes mediates a predominant myocardial inflammatory response to stretch in early volume overload. J Mol Cell Cardiol 49:70–78
Article CAS PubMed PubMed Central Google Scholar
Deonarain R, Cerullo D, Fuse K, Liu PP, Fish EN (2004) Protective role for interferon-beta in coxsackievirus B3 infection. Circulation 110:3540–3543
Article CAS PubMed Google Scholar
Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL, Baughman KL, Kasper EK (2000) Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 342:1077–1084
Article CAS PubMed Google Scholar
Feng Q, Langereis MA, Lork M, Nguyen M, Hato SV, Lanke K, Emdad L, Bhoopathi P, Fisher PB, Lloyd RE, van Kuppeveld FJ (2014) Enterovirus 2Apro targets MDA5 and MAVS in infected cells. J Virol 88:3369–3378
Article PubMed PubMed Central Google Scholar
Garrod D, Chidgey M (2008) Desmosome structure, composition and function. Biochim Biophys Acta 1778:572–587
Article CAS PubMed Google Scholar
Gwechenberger M, Mendoza LH, Youker KA, Frangogiannis NG, Smith CW, Michael LH, Entman ML (1999) Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions. Circulation 99:546–551
Article CAS PubMed Google Scholar
Halterman JA, Kwon HM, Wamhoff BR (2012) Tonicity-independent regulation of the osmosensitive transcription factor TonEBP (NFAT5). Am J Physiol Cell Physiol 302:C1–8
Article CAS PubMed Google Scholar
Honda K, Takaoka A, Taniguchi T (2006) Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. Immunity 25:349–360
Article CAS PubMed Google Scholar
Huerga Encabo H, Traveset L, Argilaguet J, Angulo A, Nistal-Villan E, Jaiswal R, Escalante CR, Gekas C, Meyerhans A, Aramburu J, Lopez-Rodriguez C (2020) The transcription factor NFAT5 limits infection-induced type I interferon responses. J Exp Med. https://doi.org/10.1084/jem.20190449
Kimura T, Flynn CT, Alirezaei M, Sen GC, Whitton JL (2019) Biphasic and cardiomyocyte-specific IFIT activity protects cardiomyocytes from enteroviral infection. PLoS Pathog 15:e1007674
Article CAS PubMed PubMed Central Google Scholar
Leonard EG (2004) Viral myocarditis. Pediatr Infect Dis J 23:665–666
Liu H, Li M, Song Y, Xu W (2018) TRIM21 Restricts coxsackievirus b3 replication, cardiac and pancreatic injury via interacting with mavs and positively regulating irf3-mediated type-i interferon production. Front Immunol 9:2479
Article PubMed PubMed Central Google Scholar
Lopez-Rodriguez C, Antos CL, Shelton JM, Richardson JA, Lin F, Novobrantseva TI, Bronson RT, Igarashi P, Rao A, Olson EN (2004) Loss of NFAT5 results in renal atrophy and lack of tonicity-responsive gene expression. Proc Natl Acad Sci U S A 101:2392–2397
Article CAS PubMed PubMed Central Google Scholar
Lowenstein CJ, Hill SL, Lafond-Walker A, Wu J, Allen G, Landavere M, Rose NR, Herskowitz A (1996) Nitric oxide inhibits viral replication in murine myocarditis. J Clin Invest 97:1837–1843
Article CAS PubMed PubMed Central Google Scholar
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M, Burri H, Butler J, Celutkiene J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A, Group ESCSD (2021) 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42:3599–3726
Article CAS PubMed Google Scholar
McNab F, Mayer-Barber K, Sher A, Wack A, O’Garra A (2015) Type I interferons in infectious disease. Nat Rev Immunol 15:87–103
Article CAS PubMed PubMed Central Google Scholar
Menard C, Pupier S, Mornet D, Kitzmann M, Nargeot J, Lory P (1999) Modulation of L-type calcium channel expression during retinoic acid-induced differentiation of H9C2 cardiac cells. J Biol Chem 274:29063–29070
Article CAS PubMed Google Scholar
Mukherjee A, Morosky SA, Delorme-Axford E, Dybdahl-Sissoko N, Oberste MS, Wang T, Coyne CB (2011) The coxsackievirus B 3C protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling. PLoS Pathog 7:e1001311
Article CAS PubMed PubMed Central Google Scholar
Ng CS, Jogi M, Yoo JS, Onomoto K, Koike S, Iwasaki T, Yoneyama M, Kato H, Fujita T (2013) Encephalomyocarditis virus disrupts stress granules, the critical platform for triggering antiviral innate immune responses. J Virol 87:9511–9522
Article CAS PubMed PubMed Central Google Scholar
Onomoto K, Jogi M, Yoo JS, Narita R, Morimoto S, Takemura A, Sambhara S, Kawaguchi A, Osari S, Nagata K, Matsumiya T, Namiki H, Yoneyama M, Fujita T (2012) Critical role of an antiviral stress granule containing RIG-I and PKR in viral detection and innate immunity. PLoS ONE 7:e43031
Article CAS PubMed PubMed Central Google Scholar
Qiu Y, Ye X, Zhang HM, Hanson P, Zhao G, Tong L, Xie R, Yang D (2017) Cleavage of osmosensitive transcriptional factor NFAT5 by coxsackieviral protease 2A promotes viral replication. PLoS Pathog 13:e1006744
Article PubMed PubMed Central Google Scholar
Rahnefeld A, Klingel K, Schuermann A, Diny NL, Althof N, Lindner A, Bleienheuft P, Savvatis K, Respondek D, Opitz E, Ketscher L, Sauter M, Seifert U, Tschope C, Poller W, Knobeloch KP, Voigt A (2014) Ubiquitin-like protein ISG15 (interferon-stimulated gene of 15 kDa) in host defense against heart failure in a mouse model of virus-induced cardiomyopathy. Circulation 130:1589–1600
Article CAS PubMed Google Scholar
Reineke LC, Lloyd RE (2013) Diversion of stress granules and P-bodies during viral infection. Virology 436:255–267
Article CAS PubMed Google Scholar
Riad A, Westermann D, Zietsch C, Savvatis K, Becher PM, Bereswill S, Heimesaat MM, Lettau O, Lassner D, Dorner A, Poller W, Busch M, Felix SB, Schultheiss HP, Tschope C (2011) TRIF is a critical survival factor in viral cardiomyopathy. J Immunol 186:2561–2570
Comments (0)